ZU Logo
Home  |  Online Registration  |  eLearning  | Contact Us  |  عربي  


Researcher Name
Prof. Abdelmonem Awad Hegazy
Name Of Journal
European Journal of Clinical and Experimental Medi
Volume No.
19(3):280–282
Date Of Publication
2022.10
Abstract
Dear Editor, With the advent of COVID-19 globally, many doctors have begun to review the medications that are already available to treat and/or protect against the infection. One of these drugs is the antiparasitic ivermectin. The first clinical trial was registered by Zagazig University in May, 2020; and hence, it has been adopted in several studies.